logo
welcome
TechCrunch

TechCrunch

From pond scum to premium skincare? Deep Blue Biotech is all in on blue-green algae to make better chemicals | TechCrunch

TechCrunch
Summary
Nutrition label

79% Informative

U.K. startup Deep Blue Biotech is building a business around a photosynthesis-based form of biomanufacturing that will enable it to manufacture chemicals in a more environmentally friendly way than conventional production methods.

The startup claims its method can achieve cost parity with conventional chemical production since the genetically engineered microorganism it’s using to produce the chemicals only requires feeding with relatively cheap ingredients: light, water and CO2.

Deep Blue Biotech is announcing an $ 800,000 pre-seed round to keep building towards a commercial MVP .

The round was led by Sustainable Ventures , with participation from One Planet Capital , PCSI , and SFC Capital .

The funding will be used to kick off their first paid pilots, entering into joint development agreements with customers to incorporate their hyaluronic acid into their own products.

VR Score

72

Informative language

66

Neutral language

53

Article tone

informal

Language

English

Language complexity

62

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

Affiliate links

no affiliate links